| Literature DB >> 31538419 |
Min Uk Jang1, Jihoon Kang2, Beom Joon Kim2, Jeong Ho Hong3, Min Ju Yeo4, Moon Ku Han2, Byung Chul Lee1, Kyung Ho Yu1, Mi Sun Oh1, Kyung Chan Choi1, Sang Hwa Lee1, Keun Sik Hong5, Yong Jin Cho5, Jong Moo Park6, Jae Kwan Cha7, Dae Hyun Kim7, Tai Hwan Park8, Kyung Bok Lee9, Soo Joo Lee10, Jun Lee11, Joon Tae Kim12, Dong Eog Kim13, Jay Chol Choi14, Juneyoung Lee15, Ji Sung Lee16, Philip B Gorelick17, Hee Joon Bae18.
Abstract
BACKGROUND: Using data from a large national stroke registry, we aimed to investigate the incidence and determinants of in-hospital and post-discharge recovery after acute ischemic stroke and the independence of their occurrence.Entities:
Keywords: Brain Infarction: Recovery of Function; Prognosis; Registries; Stroke
Mesh:
Substances:
Year: 2019 PMID: 31538419 PMCID: PMC6753366 DOI: 10.3346/jkms.2019.34.e240
Source DB: PubMed Journal: J Korean Med Sci ISSN: 1011-8934 Impact factor: 2.153
Fig. 1Distribution of mRS scores at discharge and 3 months after stroke onset. Green cells represent the post-discharge recovery group. Orange cells represent the aggravated group. Gray represent the non-changing group. Data are number of patients (%).
mRS = modified Rankin scale.
Effect of 3-month outcome determinants in in-hospital and post-discharge recovery after acute ischemic stroke
| Variables | No in-hospital recovery (n = 7,118) | In-hospital recovery (n = 3,970) | No post-discharge recovery (n = 7,418) | Post-discharge recovery (n = 3,670) | |||
|---|---|---|---|---|---|---|---|
| Age, yr | 67.75 ± 12.6 | 66.8 ± 13.1 | < 0.01 | 70.4 ± 12.0 | 65.3 ± 12.7 | < 0.001 | |
| Men | 4,119 (57.9) | 2,406 (60.6) | < 0.01 | 4,228 (57.0) | 2,297 (62.6) | < 0.001 | |
| BMI, kg/m2 | 24.1 ± 13.1 | 23.9 ± 11.1 | 0.64 | 24.0 ± 14.0 | 24.0 ± 8.2 | 0.03 | |
| Onset-to-admission time, hr | 29.0 ± 37.0 | 21.8 ± 32.1 | < 0.001 | 26.9 ± 35.5 | 26.8 ± 35.3 | 0.46 | |
| Blood glucose at admission, mg/dL | 120.5 ± 53.4 | 115.8 ± 47.0 | < 0.001 | 118.7 ± 50.0 | 119.1 ± 53.8 | 0.12 | |
| SBP at admission, mmHg | 148.6 ± 26.8 | 147.7 ± 27.1 | 0.09 | 147.8 ± 27.1 | 149.2 ± 26.6 | 0.02 | |
| Previous stroke | 1,538 (21.6) | 764 (19.2) | < 0.01 | 1,676 (21.9) | 676 (18.4) | < 0.001 | |
| Hypertension | 4,961 (69.7) | 2,727 (68.7) | 0.27 | 5,197 (70.1) | 2,491 (67.9) | 0.02 | |
| Diabetes mellitus | 2,461 (34.6) | 1,227 (30.9) | < 0.001 | 2,454 (33.1) | 1,234 (33.6) | 0.57 | |
| Hyperlipidemia | 2,397 (33.7) | 1,258 (31.7) | 0.03 | 2,390 (32.2) | 1,265 (34.5) | 0.02 | |
| Smokera | < 0.001 | < 0.001 | |||||
| Current | 1,803 (25.3) | 1,121 (28.2) | 1,862 (25.1) | 1,062 (28.9) | |||
| Ex-smoker | 657 (9.5) | 426 (10.7) | 729 (9.8) | 373 (10.2) | |||
| Non-smoker | 4,639 (65.7) | 2,423 (61.0) | 4,827 (65.1) | 2,235 (60.9) | |||
| CHF | 121 (1.7) | 60 (1.5) | 0.45 | 141 (1.9) | 40 (1.1) | 0.002 | |
| Atrial fibrillation | 1,176 (16.5) | 877 (22.1) | < 0.001 | 1,481 (20.0) | 572 (15.6) | < 0.001 | |
| NIHSS score at admission. | 3 (1–6) | 4 (2–9) | < 0.001 | 3 (1–7) | 3 (1–6) | < 0.001 | |
| Pre-stroke mRS score | < 0.001 | < 0.001 | |||||
| 2–5 | 938 (13.2) | 428 (10.8) | 1,056 (14.2) | 310 (8.4) | |||
| 0–1 | 6,180 (86.8) | 3,542 (89.2) | 6,362 (85.8) | 3,360 (91.6) | |||
| TOAST classification | < 0.001 | < 0.001 | |||||
| LAA | 2,803 (39.4) | 1,404 (35.4) | 2,748 (37.0) | 1,459 (39.8) | |||
| SVO | 1,379 (19.4) | 754 (19.0) | 1,333 (18.0) | 800 (21.8) | |||
| Cardioembolism | 1,264 (17.8) | 956 (24.1) | 1,581 (21.3) | 639 (17.4) | |||
| Other | 1,672 (23.5) | 856 (21.6) | 1,756 (23.7) | 772 (21.0) | |||
| Recanalization therapy | 608 (8.5) | 838 (21.1) | < 0.001 | 975 (13.1) | 471 (12.8) | 0.65 | |
| Prior statin use | 1,138 (16.0) | 686 (17.3) | 0.08 | 1,201 (16.2) | 623 (17.0) | 0.29 | |
| Statin use at discharge | 5,710 (80.2) | 3,193 (80.4) | 0.79 | 5,869 (79.1) | 3,034 (82.7) | < 0.001 | |
Data are presented as mean ± standard deviation or median (interquartile range) or number (%).
BMI = body mass index, SBP = systolic blood pressure, CHF = congestive heart failure, NIHSS = National Institute of Health Stroke Scale, mRS = modified Rankin scale, TOAST = Trial of Org 10172 in Acute Stroke Treatment, LAA = large artery atherosclerosis, SVO = small vessel occlusion.
aSmoking status was divided by current, ex-smoker (quit within 5 years), and non-smoker (never smoker or quit > 5 years).
Multivariate analysis for determining factors associated with in-hospital and post-discharge recovery after acute ischemic stroke
| Variables | In-hospital recovery | Post-discharge recovery | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |||
| Age, 5-year increments | 0.96a | 0.95–0.98 | 0.93a | 0.91–0.94 | < 0.01 | |
| Gender, men | 1.05 | 0.95–1.16 | 1.20a | 1.08–1.32 | 0.08 | |
| BMI, kg/m2 | 1.00 | 1.00–1.00 | 1.00 | 0.99–1.00 | 0.59 | |
| Onset-to-admission time, hr | 0.93a | 0.90–0.96 | 1.00 | 0.97–1.03 | < 0.001 | |
| Blood glucose at admission, 10 mg/dL | 0.98a | 0.97–0.99 | 1.00 | 0.99–1.01 | < 0.001 | |
| SBP at admission, 10 mmHg | 0.98a | 0.96–0.99 | 1.01 | 0.99–1.02 | 0.01 | |
| Previous stroke | 0.85a | 0.76–0.95 | 0.92 | 0.82–1.03 | 0.32 | |
| Hypertension | 1.04 | 0.95–1.14 | 0.98 | 0.89–1.08 | 0.39 | |
| Diabetes mellitus | 0.97 | 0.88–1.06 | 1.01 | 0.92–1.12 | 0.48 | |
| Smokerb | 0.02 | |||||
| Current | 1.10 | 0.99–1.23 | 0.89 | 0.80–1.00 | ||
| Ex-smoker | 1.06 | 0.93–1.21 | 0.88 | 0.77–1.00 | ||
| Non-smoker | Reference | Reference | ||||
| CHF | 0.71a | 0.51–1.00 | 0.76 | 0.53–1.10 | 0.78 | |
| Atrial fibrillation | 1.13 | 0.96–1.32 | 1.07 | 0.91–1.26 | 0.64 | |
| NIHSS score at admission | 1.05a | 1.04–1.06 | 0.99a | 0.98–0.999 | < 0.001 | |
| Pre-stroke mRS score 2–5 | 0.79a | 0.69–0.91 | 0.68a | 0.59–0.79 | 0.16 | |
| TOAST classification | 0.05 | |||||
| LAA | 0.85a | 0.76–0.95 | 0.98 | 0.87–1.09 | ||
| SVO | Reference | Reference | ||||
| Cardioembolism | 0.90 | 0.76–1.07 | 0.77a | 0.65–0.92 | ||
| Other | 0.80a | 0.70–0.91 | 0.79a | 0.69–0.90 | ||
| Recanalization therapy | 1.99a | 1.75–2.26 | 1.12 | 0.97–1.28 | < 0.001 | |
| Prior statin use | 1.13a | 1.01–1.27 | 1.08 | 0.96–1.21 | 0.55 | |
| Statin use at discharge | 1.11 | 1.00–1.24 | 1.18a | 1.06–1.32 | 0.40 | |
The relationship between in-hospital and post-discharge recovery had a correlation coefficient of 0.004.
OR = odds ratio, CI = confidence interval, BMI = body mass index, SBP = systolic blood pressure, CHF = congestive heart failure, NIHSS = National Institute of Health Stroke Scale, mRS = modified Rankin scale, TOAST = Trial of Org 10172 in Acute Stroke Treatment, LAA = large artery atherosclerosis, SVO = small vessel occlusion.
aStatistically significant with P < 0.05; bSmoking status was divided by current, ex-smoker (quit within 5 years), and non-smoker (never smoker or quit > 5 years).
Fig. 2Incidence of in-hospital and post-discharge recovery after acute ischemic stroke.